This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignee: Exosome Diagnostics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Georg Stoll: Innovator in Bladder Cancer Detection
Introduction
Georg Stoll is a prominent inventor based in Munich, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection and treatment of bladder cancer. With a focus on innovative methods and technologies, Stoll has secured a total of 2 patents that reflect his expertise and dedication to advancing healthcare solutions.
Latest Patents
Stoll's latest patents include groundbreaking methods for developing urine biomarkers and detecting bladder cancer. The first patent relates to methods for detecting and treating bladder cancer in a subject using gene expression level measurements from exosomes derived from the subject. This innovative approach aims to enhance the accuracy of bladder cancer detection and improve treatment outcomes. The second patent focuses on compositions and methods for internal controls of microvesicle isolations. This patent provides compositions, methods, and kits that can include enveloped viruses, such as inactive mouse hepatitis virus (MHV), to ensure reliable microvesicle isolation processes.
Career Highlights
Georg Stoll has established himself as a key figure in the field of medical diagnostics. His work at Exosome Diagnostics, Inc. has allowed him to collaborate with other experts in the field and contribute to the development of cutting-edge diagnostic tools. His innovative spirit and commitment to research have positioned him as a leader in the industry.
Collaborations
Stoll has worked alongside notable colleagues, including Daniel Enderle and Mikkel Noerholm. These collaborations have fostered an environment of innovation and have led to advancements in the understanding and detection of bladder cancer.
Conclusion
Georg Stoll's contributions to the field of bladder cancer detection through his innovative patents and collaborations highlight his commitment to improving medical diagnostics. His work continues to pave the way for advancements in healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile